Format
Sort by

Send to

Choose Destination

Search results

Items: 10

1.

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.

Hitt R, Grau JJ, López-Pousa A, Berrocal A, García-Girón C, Irigoyen A, Sastre J, Martínez-Trufero J, Brandariz Castelo JA, Verger E, Cruz-Hernández JJ; Spanish Head and Neck Cancer Cooperative Group (TTCC).

Ann Oncol. 2014 Jan;25(1):216-25. doi: 10.1093/annonc/mdt461. Epub 2013 Nov 19.

2.

Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study.

Jolis L, Carabantes F, Pernas S, Cantos B, López A, Torres P, Funes C, Caballero D, Benedit P, Salar A; PRAXIS Study Group.

Eur J Cancer Care (Engl). 2013 Jul;22(4):513-21. doi: 10.1111/ecc.12057. Epub 2013 Jun 3.

PMID:
23730920
3.

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.

4.

E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma.

Santos-García A, Abad-Hernández MM, Fonseca-Sánchez E, Julián-González R, Galindo-Villardón P, Cruz-Hernández JJ, Bullón-Sopelana A.

Med Oral Patol Oral Cir Bucal. 2006 Mar 1;11(2):E100-5. English, Spanish.

5.

Proteic expression of p53 and cellular proliferation in oral leukoplakias.

Santos-García A, Abad-Hernández MM, Fonseca-Sánchez E, Cruz-Hernández JJ, Bullón-Sopelana A.

Med Oral Patol Oral Cir Bucal. 2005 Jan-Feb;10(1):5-8; 1-5. English, Spanish.

6.

[Survival rate in epidermoid carcinoma of the oral cavity].

Muñoz Herrera A, Santa Cruz Ruiz S, Fonseca Sánchez E, Nieto Palacios A, Blanco Pérez P, Gómez González JL.

Acta Otorrinolaringol Esp. 2001 Jun-Jul;52(5):381-6. Spanish.

7.

[Results of treating cervical metastases of an unknown primary tumor. A report of 29 cases].

Rodríguez Gutiérrez A, Calvo Boizas E, Alonso Rodríguez O, Soria Carreras P, Solbes Solbes R, Soler Ripoll JJ, Gómez González JL, Fonseca Sánchez E.

Acta Otorrinolaringol Esp. 1999 May;50(4):305-9. Spanish.

PMID:
10431080
8.

[Quantification of serum alpha-1 antitrypsin as a biological marker in cancer].

Chimpén Ruiz V, Fonseca Sánchez E, Cruz Hernández JJ, Fermoso García J.

Rev Clin Esp. 1985 Nov;177(8):419-20. Spanish. No abstract available.

PMID:
3879736
9.

[Levels of alpha 1-antitrypsin in the serum of neoplasm patients].

Fonseca Sánchez E, Chimpén Ruiz V, López Berges C, Fermoso García J, de Portugal Alvarez J.

Med Clin (Barc). 1983 Nov 26;81(17):752-4. Spanish. No abstract available.

PMID:
6606747
10.

[Distribution of the haptoglobin phenotype in various neoplasms].

Fonseca Sánchez E, Chimpen Ruiz V, López Berges C, Fermoso García J.

Med Clin (Barc). 1983 Sep 17;81(7):321. Spanish. No abstract available.

PMID:
6645677
Items per page

Supplemental Content

Loading ...
Write to the Help Desk